CTOs on the Move

CIC Health

www.cic-health.com

 
CIC Health provides COVID-19 testing services to organizations and individuals. We simplify testing by integrating CLIA-certified laboratories, physician oversight, result reporting, and billing software. Whether a one-time test or routine testing for a business, school, care facility, or consumers, our services are accessible, fast, and easy.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Vinay Gidwaney
Head of Technology Profile

Similar Companies

USANA

USANA Health Sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent Associates, shareholders, and employees. We’ve got history. Not baggage. We’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). And we look great for our age. Plus, we have substance to go along with our great looks. We’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. We have an award-winning compensation plan and award-winning products. We don’t like to brag, but we come pretty highly recommended. That’s because we got off on the right foot.

Barbara Davis Ct Chldhd Diabts

Barbara Davis Ct Chldhd Diabts is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fitness Connection

This website is for sale! fitnessconnectionusa.com is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, fitnessconnectionusa.com has it all. We hope you find wha...

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Healthcare Management Administrators

HMA is a regional third-party healthcare benefits administrator, dedicated to helping the companies we service improve their employee and family health and wellbeing through customized benefits plans and innovative support services.